STOCKHOLM, Sweden, Sept. 26, 2002 (PRIMEZONE) -- The Swedish inventor of modular high-tech facilities -- Pharmadule Emtunga AB -- announces steps to secure its rapid-expansion and patent protect its technological leadership, covering fabrication and sales of Modular Biotechnological Plants.
Pharmadule Emtunga has made a substantial expansion of its production capacity by entering into a strategic production alliance and by establishing a new facility in Partille, Gothenburg region, generating a positive and lasting impact on Pharmadule Emtungas's capacity to meet the increasing production and volume demand from today's market and into the future.
Pharmadule Emtunga is the number 1 modular supplier in the world to the pharmaceutical and biotech industry. The company has a long and extensive history -- since the early seventies with extensive experience in the development of modular fabrication -- with the pharmaceutical and biotech industry. This innovative concept has enabled them to supply large complex facilities (larger than 10,000 sq. m and up to 12 months faster) when compared with conventional construction.
Division Pharmadule now further strengthens its technical leadership as the world-leading supplier of modular facilities by announcing the acquisition of EU, U.S. and Canadian patents, EP 0 670889, U.S. 5656 491 and Cda 2137 671. The patents relate to construction and sales of Mobile Modular Biotechnological plants. Pharmadule is rapidly growing and investing heavily in the development of the modular concept for the Biotech industry. The acquisition of the patents is a logical step to assure that Pharmadule can keep developing technological skills for the benefit of their customers and partners.
Pharmadule Emtunga AB is the leading supplier of high-quality modular facilities in the world. Its activities encompass three different market segments, that all share modular technology, engineering and production resources. As of today, division Pharmadule has supplied more than 40 plants worldwide to multi-national companies such as Eli Lilly, Merck, Aventis Pasteur, AstraZeneca. Division Emtunga has delivered more than 100 projects to the oil and gas industry and division. FlexEnclosure has several thousand base stations for mobile telecom networks worldwide. The company has manufacturing plants in Sweden. Sales offices are located in Seattle and Houston, USA, Moscow, Russia and Stavanger, Norway. www.pharmadule.com
This information was brought to you by Waymaker: http://www.waymaker.net
The following files are available for download:
http://www.waymaker.net/bitonline/2002/09/26/20020926BIT00410/wkr0001.doc http://www.waymaker.net/bitonline/2002/09/26/20020926BIT00410/wkr0002.pdf